Clinical Trials Arena on MSN19h
MedUni Vienna physicians develop tool to enhance trial access
Operated by MedUni Vienna spin-off Dayotec, the platform aims to provide countrywide access to trials for subjects.
The American Journal of Managed Care11h
ESA Treatment Improves OS in Lower-Risk MDS
Erythropoiesis-stimulating agent (ESA) treatment before or early after regular transfusion therapy improved overall survival ...
BioPharma Dive6h
FDA approves first-of-its-kind RNA drug for hemophilia
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
TipRanks on MSN13h
Milestone CRL affirms integrity of clinical data, says H.C. Wainwright
H.C. Wainwright keeps a Buy rating on Milestone Pharmaceuticals (MIST) after the company announced receipt of a complete response letter from the ...
MPR14h
Fabhalta Approved as First Treatment for C3 Glomerulopathy
The approval of iptacopan in reducing proteinuria in adult patients with native kidney C3G was based on data from the randomized, double-blind, placebo-controlled, phase 3 APPEAR-C3G trial.
The American Journal of Managed Care10h
FDA Approves Fitusiran for Reducing Bleeds in Patients With Hemophilia A/B
Data from the ATLAS research comprises a series of trials that have yielded years of long-term, comprehensive data on safety ...